Published in Curr Treat Options Oncol on June 01, 2010
Metabolomics of gastric cancer metastasis detected by gas chromatography and mass spectrometry. World J Gastroenterol (2010) 0.99
D2 lymphadenectomy is not only safe but necessary in the era of neoadjuvant chemotherapy. World J Surg Oncol (2013) 0.92
Clinical implications of DLL4 expression in gastric cancer. J Exp Clin Cancer Res (2013) 0.84
Elevated expression of NEDD9 is associated with metastatic activity in gastric cancer. Onco Targets Ther (2015) 0.81
Risk factors for nonsynchronous second primary malignancy and related death in patients with differentiated thyroid carcinoma. Ann Surg Oncol (2011) 0.81
Urine Metabolite Profiling of Human Colorectal Cancer by Capillary Electrophoresis Mass Spectrometry Based on MRB. Gastroenterol Res Pract (2012) 0.81
Metabolomic studies of human gastric cancer: review. World J Gastroenterol (2014) 0.78
High-Throughput Sequencing of miRNAs Reveals a Tissue Signature in Gastric Cancer and Suggests Novel Potential Biomarkers. Bioinform Biol Insights (2015) 0.76
Ion chromatography based urine amino Acid profiling applied for diagnosis of gastric cancer. Gastroenterol Res Pract (2012) 0.76
Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinoma. Radiol Oncol (2014) 0.76
Efficacy of a hypotonic treatment for peritoneal dissemination from gastric cancer cells: an in vivo evaluation. Biomed Res Int (2014) 0.76